Recruiting
Phase 2

Ublituximab

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT07103746

Conditions

Autoimmune Disorders

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ublituximab

Placebo for Ublituximab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-11. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2026-04-08.